Evaluation of the expression of angiogenic factors in breast cancer after curcumin treatment by unknown
POSTER PRESENTATION Open Access
Evaluation of the expression of angiogenic
factors in breast cancer after curcumin treatment
Lívia C Ferreira2,3*, Bruna V Jardim2,3, Thaiz F Borin1,3, Marina G Moschetta1,3, Gabriela B Gelaleti2,3,
Larissa B Maschio3, Camila Leonel2,3, Juliana R Lopes2,3, Naiane N Gonçalves3, Gustavo R Martins1,3,
Debora APC Zuccari3
From São Paulo Advanced School of Comparative Oncology
Águas de São Pedro, Brazil. 30 September - 6 October 2012
Background
Angiogenesis plays an important role in the pathogenesis
of several malignancies, including breast cancer. Tumor
growth requires the formation of new blood vessels that
are stimulated by angiogenic factors, which initiates the
sprouting and proliferation of endothelial cells. Curcumin
is used as food and in traditional medicine, however evi-
dences indicate that rhizome has anticancer effects
against different types of cancers. We evaluated the
effects of curcumin treatment on angiogenesis in breast
cancer.
Materials and methods
Breast cancer cell line MDA-MB-231 was cultured in
vitro in DMEM high glucose at 37°C in 5% CO2. Cell via-
bility was measured by MTT assay with three concentra-
tions of curcumin (10ug, 20ug and 40ug), in 4 hours and
24 hours. In vivo, cells were injected subcutaneously in
mammary gland in athymic nude mice, and each animal
received daily 7,5mg of curcumin administred intraperi-
toneally. Tumor size was measured weekly and angio-
genic factors were evaluated in breast tumors.
Results
There was a significantly decrease in cells viability after
treatment with curcumin (all concentrations). In addition,
results showed that 40ug of curcumin was able to reduced
88% of cell viability after 24 hours. Furthermore, the action
of curcumin as anti-angiogenic agent was tested in breast
cancer xenografts established in nude mice.
Conclusions
The highest dose of curcumin was considered the opti-
mal concentration for in vitro treatment. This study was
an innovative way to evaluate the potential effectiveness
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